WuXi starts up construction of China's largest biologics plant

WuXi Biologics is embarking on construction of a new manufacturing facility that will be the biggest biologics plant in China. It'll also be the world's largest facility for mammalian cell culture manufacturing using disposable bioreactors once it's completed--an event the company expects by the end of next year. More from FiercePharmaAsia

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.